(Q39637230)

13 September 2017

title

Use of biosimilar epoetin to increase hemoglobin levels in patients with chemotherapy-induced anemia: real-life clinical experience (English)

1 reference

13 September 2017

1 reference

Leon Kerkhofs

1

1 reference

13 September 2017

Gilles Boschetti

2

1 reference

13 September 2017

Antonio Lugini

3

1 reference

13 September 2017

Dana-Lucia Stanculeanu

4

1 reference

13 September 2017

Andrés Garcia Palomo

5

1 reference

13 September 2017

language of work or name

English

0 references

publication date

23 March 2012

1 reference

13 September 2017

1 reference

13 September 2017

volume

8

1 reference

13 September 2017

issue

6

1 reference

13 September 2017

page(s)

751-756

1 reference

American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer

13 September 2017

cites work

1 reference

Update on erythropoiesis-stimulating agents and clinical trials in oncology

21 January 2018

1 reference

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes

21 January 2018

1 reference

21 January 2018

1 reference

Making progress against cancer in Europe in 2008.

21 January 2018

1 reference

21 January 2018

1 reference

Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple intravenous administrations: an open-label randomised controlled trial

21 January 2018

1 reference

Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple subcutaneous administrations

21 January 2018

1 reference

HX575, recombinant human epoetin alfa, for the treatment of chemotherapy-associated symptomatic anaemia in patients with solid tumours

21 January 2018

1 reference

Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study.

21 January 2018

1 reference

Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial

21 January 2018

1 reference

Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia

21 January 2018

1 reference

Delivering affordable cancer care in high-income countries

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FON.12.39

1 reference

13 September 2017

1 reference